-
McIlroy on the charge at PGA Championship
-
Czechs level Davis Cup tie against USA as South Korea eye Finals
-
Crisis-wracked Volkswagen warns of 10-bn-euro hit to profits
-
New France boss Zidane confirms Mbappe as captain after naming first squad
-
Costa Rica's Grynspan tops third informal poll for UN chief: diplomat
-
California governor signs order to explore AI 'kill switch'
-
Stock markets retreat after central bank rate hikes
-
Head leads run spree as Australia win Zimbabwe ODI series
-
Russia labels director of Cannes Grand Prix winner a 'foreign agent'
-
In-form Raphinha wants to finish career at Barcelona
-
Macron warns of Russian 'hybrid' threat after meeting presidential hopefuls
-
Warren Buffett steps down as Berkshire Hathaway chairman
-
UN holds third informal poll for new chief
-
Carrick confident Man Utd can 'work through' tough time
-
Kulusevski return can spark Spurs: De Zerbi
-
Mbappe ends Nike partnership to join Swiss brand On
-
Shakira to cap off world tour with Madrid 12-gig run
-
Liverpool boss Iraola puts Bournemouth love affair on hold
-
Isolated Syrian-Druze city blames Damascus for shortages
-
'A disaster' if Man City do not win says Maresca after flawless start
-
Isolated Syrian-Druze city shortages
-
Kerry James Marshall: American 'blackness' painter celebrated in Europe
-
Dutch drop Depay for Germany match in Xavi's first pick
-
Spain coach De la Fuente offers 'full support' to people of Ceuta
-
Ronaldo named in Portugal squad for Nations League
-
Russia seizes assets of Nestle, French firms over West's Ukraine support
-
Stock markets diverge after central bank rate hikes
-
England can build on World Cup 'spirit', says Tuchel
-
Anti-Assad music star makes triumphant return to Syria
-
UNESCO can be 'moderator' in AI debate: chief to AFP
-
In-form Fernandez included in Spain Nations League squad
-
Infantino 'must go', says German FA vice-president
-
Arteta buries hatchet with Hurzeler ahead of Brighton clash
-
Russia seizes assets of Nestle, French firms
-
Alexander-Arnold and Palmer return to England squad for Nations League
-
Japan's busiest rail station tests robot bins
-
Russians vote as Ukraine war drags on for fifth year
-
Anthropic says AI systems moving towards building themselves
-
Backpackers fret over Australian visa crackdown
-
Asian stocks boosted by falling oil, yen weakens after BoJ rate hike
-
Most Asian stocks track Wall St rally, yen drops after BoJ rate hike
-
Pakistan court blocks expulsion of Afghan medical college students
-
Russians begin voting in controlled election as war drags on
-
Athletes 'can't take it any more' as Asian Games issues mount
-
Trump 'clearly' wants dialogue with Pyongyang: South Korean President
-
Allen lights up Bills' new stadium with 41-31 win over Lions
-
Bank of Japan hikes rates to 31-year high to battle inflation
-
Afghan medical students in Pakistan hope court stops college expulsions
-
Thailand's Muslim separatists vow to fight to the end
-
AI doomsday warnings unlikely to slow IPOs but questions linger
US expands access to abortion pills through pharmacies
Retail pharmacies in the United States will be permitted to sell abortion pills, health officials said Tuesday, a move that could significantly expand access to the procedure after last year's landmark Supreme Court ruling that overturned federal abortion rights.
Regulatory changes announced by the Food and Drug Administration mean that mifepristone, which is the first of two drugs used to terminate a pregnancy, will be available in local drug stores in states where abortion is permitted.
A doctor's prescription will be needed to obtain the pills, which were previously only available from a few mail-order pharmacies or certified doctors and clinics.
Demand for abortion pills has risen since the conservative-dominated Supreme Court made a landmark ruling last June that overturned Roe v. Wade, a 1973 case that had guaranteed women's right to an abortion for half a century.
Abortion pills are already used in more than half of US procedures to terminate a pregnancy, experts say, and they have increasingly become a focus in the political and legal battle for abortion rights since the Supreme Court's controversial decision.
Pharmacies will need to receive certification to dispense the drug, while patients will need to complete a consent form.
The FDA's decision was welcomed by the American Civil Liberties Union.
"We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency's needless burdens on mifepristone patients," said Julia Kaye of the ACLU's Reproductive Freedom Project.
Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony List slammed the decision.
"The Biden administration has once again proved that it values abortion industry profits over women's safety and unborn children's lives," Dannenfelser said in a statement.
Ch.Campbell--AT